AML
News
Study reveals germline variants in AML, other cancers
A study published in Nature Communications has shed light on the hereditary elements of 12 cancer types. Investigators looked for rare germline...
News
Protein discovery could have therapeutic implications
Photo courtesy of The Scripps Research Institute New research shows how NPM1—a protein implicated in non-Hodgkin lymphoma, acute myelogenous...
Conference Coverage
Chemo quadruples risk for myeloid cancers
Key clinical point: This study quantifies the risks for treatment-related myeloid cancers after chemotherapy. Major finding: Chemotherapy is...
News
A potential target for IDH1-mutant cancers
acute myeloid leukemia Researchers say they have identified a potential therapeutic target for IDH1-mutant malignancies. Preclinical experiments...
Conference Coverage
Academic hospitals offer better AML survival
Key clinical point: Academic hospitals tend to have better short- and long-term mortality for patients with AML than nonacademic hospitals. Major...
News
Genes can stop onset of AML, study suggests
Image by Lance Liotta Two genes can stop the development of acute myeloid leukemia (AML), according to research published in the Journal of...
News
Minimal residual disease predicts outcome of allogeneic HCT in acute myeloid leukemia
Patients with acute myeloid leukemia (AML) who are in remission but with minimal residual disease (MRD) have outcomes similar to those of patients...
Conference Coverage
RATIFY trial results available after almost 10 years in the making
Photo courtesy of ASH ORLANDO, FL—After almost 10 years, during which time no new drug for acute myeloid leukemia (AML) has been approved,...
Conference Coverage
VIDEO: High-intensity conditioning stands ground in MDS, AML
Video
VIDEO: Midostaurin hits mark in FLT3-mutated AML
The oral multikinase inhibitor midostaurin improved overall survival by 23% when added to standard chemotherapy and given as maintenance therapy...
News
Team identifies potential biomarkers for AML therapy
Photo by Kristin Gladney New research published in Cell Reports has revealed biomarkers that may help predict which acute myeloid leukemia (AML)...